New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders.

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He ...

A new study found GLP-1 drugs were associated with 50% fewer substance-related deaths, 39% fewer drug overdoses, and 26% ...

Researchers at Washington University School of Medicine in St. Louis have shown in a new study that GLP-1 medications may be ...

Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be effective at treating and ...

With the rise of obesity drugs a pair of Penn State researchers set out to answer a question: could drugs aimed at weight loss help battle opioid addiction? Researchers Dr. Patricia Grigson and Dr.

Remarkable scientific progress over the past five decades has helped us develop knowledge of how drugs of abuse induce pleasure, reinforce use, and lead to the compulsive self-administration we call ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has strengthened warnings about the risks of dependence, addiction, withdrawal, and tolerance linked to several classes of central ...